CDX2 Expression and Fluoropyrimidine Response in Rare Non-GI Tumors: A Three-Case Series.

Suleiman R, Garcia AD, Baral B, Halfdanarson T, Fuentes-Bayne H

Open source

DOI
10.3390/curroncol33020126
Published
2026 Feb 21
Container
Current oncology (Toronto, Ont.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/curroncol33020126,
  title = {CDX2 Expression and Fluoropyrimidine Response in Rare Non-GI Tumors: A Three-Case Series.},
  author = {Suleiman R and Garcia AD and Baral B and Halfdanarson T and Fuentes-Bayne H},
  year = {2026},
  journal = {Current oncology (Toronto, Ont.)},
  doi = {10.3390/curroncol33020126},
  url = {https://doi.org/10.3390/curroncol33020126}
}

RIS

TY  - JOUR
TI  - CDX2 Expression and Fluoropyrimidine Response in Rare Non-GI Tumors: A Three-Case Series.
AU  - Suleiman R
AU  - Garcia AD
AU  - Baral B
AU  - Halfdanarson T
AU  - Fuentes-Bayne H
PY  - 2026
JO  - Current oncology (Toronto, Ont.)
DO  - 10.3390/curroncol33020126
UR  - https://doi.org/10.3390/curroncol33020126
ER  - 

APA

R, S., AD, G., B, B., T, H., & H, F. (2026). CDX2 Expression and Fluoropyrimidine Response in Rare Non-GI Tumors: A Three-Case Series.. Current oncology (Toronto, Ont.). https://doi.org/10.3390/curroncol33020126

Source records